Informações:
Falhas:
Palavras-chave
Endometrium Carcinomas ×
- Clinical Trial (70)
- Treatment Form (18)
- Follow-Up Studies (12)
- Breast Neoplasms (9)
- On-Study Form (8)
- Registration (6)
- Eligibility Determination (6)
- Quality of Life (4)
- Pathology (4)
- Gynecology (3)
- Laboratories (3)
- Adverse event (2)
- Pulmonary Medicine (1)
- Comorbidity (1)
- Toxicity Tests (1)
- Lost to Follow-Up (1)
- Pre-Study Form (1)
- Disease Response (1)
- Non Small Cell Lung Cancer (1)
- Drug Therapy (1)
- Gastroenterology (1)
- Neoplasms (1)
- Ovarian Neoplasms (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
70 Resultados da pesquisa.
Grupos de itens: HEADER MODULE, RADIATION DESCRIPTION, RADIATION DESCRIPTION2, MAGNIFICATION FACTOR, CONTACT INFORMATION, COMMENTS
Grupos de itens: HEADER MODULE, RADIATION DESCRIPTION, RADIATION DESCRIPTION2, MAGNIFICATION FACTOR, CONTACT INFORMATION, COMMENTS
Grupos de itens: HEADER MODULE, RADIATION DESCRIPTION, RADIATION DESCRIPTION2, MAGNIFICATION FACTOR, CONTACT INFORMATION, COMMENTS
Grupos de itens: HEADER MODULE, RADIATION DESCRIPTION, RADIATION DESCRIPTION2, MAGNIFICATION FACTOR, CONTACT INFORMATION, COMMENTS
Grupos de itens: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION
Grupos de itens: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, FOOTER MODULE, CCRR MODULE
Grupos de itens: HEADER MODULE, TREATMENT SCHEDULE, OFF-TREATMENT REASON, FOOTER MODULE, CCRR MODULE
Grupos de itens: HEADER MODULE, ADVERSE EVENTS - SECTION 1, ADVERSE EVENTS - SECTION 2, ADVERSE EVENTS - SECTION 3, FOOTER MODULE, CCRR MODULE
Grupos de itens: HEADER MODULE, UTERINE CANCER: DISEASE DESCRIPTION, Lymph Node Metastasis, COMMENTS
Grupos de itens: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS
Grupos de itens: HEADER MODULE, RADIATION LOCATION, RADIATION TREATMENT SUMMARY, COMMENTS
Grupos de itens: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS